Related references
Note: Only part of the references are listed.Iron chelation may harm patients with COVID-19
Michael D. Garrick et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Barnaby Edward Young et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Leukoerythroblastic reaction in a patient with COVID-19 infection
Anupam Mitra et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
COVID-19 Does Not Lead to a Typical Acute Respiratory Distress Syndrome
Luciano Gattinoni et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Cytokine storm syndrome in severe COVID-19
Piero Ruscitti et al.
AUTOIMMUNITY REVIEWS (2020)
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Serena Colafrancesco et al.
AUTOIMMUNITY REVIEWS (2020)
COVID-19 in the heart and the lungs: could we Notch the inflammatory storm?
Paola Rizzo et al.
BASIC RESEARCH IN CARDIOLOGY (2020)
COVID-19 presenting as stroke
Akshay Avula et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action
Anastasios Kollias et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Cardiovascular factors predicting poor outcome in COVID-19 patients
Ajay Kumar Mishra et al.
CARDIOVASCULAR PATHOLOGY (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
COVID-19 and Cardiovascular Disease
Kevin J. Clerkin et al.
CIRCULATION (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
COVID-19 and Multiorgan Response
Sevim Zaim et al.
CURRENT PROBLEMS IN CARDIOLOGY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19 pneumonia: different respiratory treatments for different phenotypes?
Luciano Gattinoni et al.
INTENSIVE CARE MEDICINE (2020)
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Waleed Alhazzani et al.
INTENSIVE CARE MEDICINE (2020)
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
Marco Ranucci et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
What should a cardiologist know about coronavirus disease 2019?
Grzegorz Slawinski et al.
KARDIOLOGIA POLSKA (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Ricardo J. Jose et al.
LANCET RESPIRATORY MEDICINE (2020)
Understanding pathways to death in patients with COVID-19
Jean-Louis Vincent et al.
Lancet Respiratory Medicine (2020)
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Jason Phua et al.
LANCET RESPIRATORY MEDICINE (2020)
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
Piero Ruscitti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences
Piero Ruscitti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning
Yehuda Shoenfeld
AUTOIMMUNITY REVIEWS (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
Carlo Perricone et al.
IMMUNOLOGIC RESEARCH (2020)
The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
Weiyi Tan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
Piero Ruscitti et al.
SCIENTIFIC REPORTS (2020)
Iron and Heart Failure Diagnosis, Therapies, and Future Directions
Kambiz Ghafourian et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Dennis McGonagle et al.
LANCET RHEUMATOLOGY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
Alessia Alunno et al.
RMD OPEN (2020)
Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities
Aleksandra Paterek et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron
Srinivas Abbina et al.
ACS CENTRAL SCIENCE (2019)
Ferritin Light Chain Confers Protection Against Sepsis-Induced Inflammation and Organ Injury
Abolfazl Zarjou et al.
FRONTIERS IN IMMUNOLOGY (2019)
Pathological Roles of Iron in Cardiovascular Disease
Motoi Kobayashi et al.
CURRENT DRUG TARGETS (2018)
Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community
Ijsbrand T. Klip et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Hyperferritinemia and inflammation
Kate F. Kernan et al.
INTERNATIONAL IMMUNOLOGY (2017)
The association of ferritin with cardiovascular and all-cause mortality in community-dwellers: The English longitudinal study of ageing
Nikolaos P. E. Kadoglou et al.
PLOS ONE (2017)
Modulation of Antiviral Immunity by Heme Oxygenase-1
Janyra A. Espinoza et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Model-Based Optimisation of Deferoxamine Chelation Therapy
Francesco Bellanti et al.
PHARMACEUTICAL RESEARCH (2016)
Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats
Suwakon Wongjaikam et al.
PLOS ONE (2016)
Hyperferritinemic syndrome: Still's disease and catastrophic antiphospholipid syndrome triggered by fulminant Chikungunya infection: a case report of two patients
Juan-Felipe Betancur et al.
CLINICAL RHEUMATOLOGY (2015)
Macrophage and epithelial cell H-ferritin expression regulates renal inflammation
Subhashini Bolisetty et al.
KIDNEY INTERNATIONAL (2015)
Macrophage activation syndrome and cytokine-directed therapies
Grant S. Schulert et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2014)
Suppression of immunoglobulin production in human peripheral blood mononuclear cells by monocytes via secretion of heavy-chain ferritin
Makiko Yamashita et al.
IMMUNOBIOLOGY (2014)
Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases
Etheresia Pretorius et al.
INTEGRATIVE BIOLOGY (2014)
The Hyperferritinemic Syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome
Cristina Rosario et al.
BMC MEDICINE (2013)
Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients
Gisele Zandman-Goddard et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Classification of the Disorders of Hemoglobin
Bernard G. Forget et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)
Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation-Myocardial Infarction
William Chan et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Iron enhances generation of fibrin fibers in human blood: Implications for pathogenesis of stroke
Boguslaw Lipinski et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2012)
Cardiac Protection by Preconditioning Is Generated via an Iron-Signal Created by Proteasomal Degradation of Iron Proteins
Baruch E. Bulvik et al.
PLOS ONE (2012)
Iron Regulatory Protein 1 Outcompetes Iron Regulatory Protein 2 in Regulating Cellular Iron Homeostasis in Response to Nitric Oxide
Agnieszka Stys et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Serum ferritin: Past, present and future
Wei Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2010)
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
Lyora A. Cohen et al.
BLOOD (2010)
Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death
Nikolaus Bresgen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Naive Human T Cells Are Activated and Proliferate in Response to the Heme Oxygenase-1 Inhibitor Tin Mesoporphyrin
Trevor D. Burt et al.
JOURNAL OF IMMUNOLOGY (2010)
Specific iron chelators determine the route of ferritin degradation
Ivana De Domenico et al.
BLOOD (2009)
Ferritin Functions as a Proinflammatory Cytokine via Iron-Independent Protein Kinase C Zeta/Nuclear Factor KappaB-Regulated Signaling in Rat Hepatic Stellate Cells
Richard G. Ruddell et al.
HEPATOLOGY (2009)
Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Iron status and oxidative stress biomarkers in adults: A preliminary study
Juliana Frossard Ribeiro Mendes et al.
NUTRITION (2009)
Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation
Leticia Castillo et al.
PEDIATRIC CRITICAL CARE MEDICINE (2009)
Daily supplementation with iron increases lipid peroxidation in young women with low iron stores
Sarah M. King et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity
Stefania Recalcati et al.
JOURNAL OF AUTOIMMUNITY (2008)
Ferritin -: A mediator of apoptosis?
Nikolaus Bresgen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome
Ivana De Domenico et al.
EMBO JOURNAL (2006)
Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis
D Mewar et al.
ARTHRITIS AND RHEUMATISM (2005)
Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure
T Karram et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors
Y Ishiyama et al.
HYPERTENSION (2004)
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor
H Hofmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3
LA Kubasiak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Reactive haemophagocytic syndrome in children with inflammatory disorders.: A retrospective study of 24 patients
JL Stéphan et al.
RHEUMATOLOGY (2001)
Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production
CP Gray et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Effects of hyperoxia and iron on iron regulatory protein-1 activity and the ferritin synthesis in mouse peritoneal macrophages
K Kuriyama-Matsumura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
Down-regulation of iron regulatory protein 1 gene expression by nitric oxide
L Oliveira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
